Compare Ginkgo Bioworks Holdings Inc (DNA) vs Hims and Hers Health Inc (HIMS) Price & Performance

Ginkgo Bioworks Holdings IncTrade

Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs Hims and Hers Health Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.24 (market cap $505.73M), while Hims and Hers Health Inc trades at $29.65 (market cap $7.12B). The key difference: Hims and Hers Health Inc is far larger — about 14.1× Ginkgo Bioworks Holdings Inc's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.

	DNA	HIMS
Market Cap	$505.73M	$7.12B
Sector	Health	Health
52-Week High	$16.14	$62.76
52-Week Low	$5.48	$14.52
Enterprise Value	$607.68M	$7.82B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

No Aura AI signal available yet.

Hims and Hers Health Inc

HIMS stock declined 7.11% to $29.51 following mixed Q2 2026 results, where revenue beat expectations but the company posted a wider-than-expected loss. The technical picture is neutral with bearish moving average signals, while fundamentals show strong revenue growth but deteriorating margins. Recent news highlights margin pressure from GLP-1 drug investments and an FTC investigation, creating investor uncertainty despite raised revenue guidance.

The outlook remains cautious as strong subscriber growth and AI initiatives are offset by profitability challenges and regulatory scrutiny. Investment opportunity exists in the company's expanding global footprint and raised revenue targets, but risks include margin compression, negative cash flow trends, and ongoing legal investigations that could pressure the stock near-term.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DNA

View details →

HIMS

Hims & Hers reports strong Q2 revenue growth but wider loss amid legal challengesAndrew Wynn · 20 hours agoBearish Anthropic to embed permanent watermarks in EU AI content; Sea Limited beats Q2 revenue; 7Up refreshes flavor and branding.Seeking Alpha · 23 hours agoNeutral Hims & Hers Q2 revenue beats estimates but loss widens due to restructuring chargesProactive Investors · 1 day agoNeutral View details →

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.